P3 Health Partners Inc. PIII
7.05
0.00
0.00%
as of 25 Sep
- Market cap
- $51.2M
- P/E
- 0.0×
Follow PIII
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(257.39%) | 373.15% | 314.44% | 461.69% | |
| (17.28%) | (20.55%) | (17.32%) | (15.59%) | ||
ROIC |
(81.39%) | (182.89%) | (98.45%) | (54.24%) | |
Return on Tangible Assets |
46.07% | 36.19% | 36.04% | 52.25% | |
Average Days of Receivables |
21.66 | 23.97 | 33.21 | 35.13 | |
Free Cash Flow per Share |
(38.01) | (27.94) | (25.92) | (38.82) | |
Free Cash Flow |
(124.23) | (91.33) | (85.24) | (130.52) | |
Capital Expenditures |
(1.48) | (0.10) | — | — | |
Piotroski F-Score |
2.00 | 2.00 | 3.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(45.01%) | (63.37%) | (43.85%) | (60.52%) | |
Accounts Receivable Turnover |
13.66 | 13.20 | 10.96 | 12.24 | |
Accounts Payable Turnover |
4.99 | 4.41 | 4.35 | 5.11 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
76.98 | 88.73 | 85.10 | 63.18 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.03 | 0.01 | (0.04) | (0.05) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.12% | 7.35% | 7.32% | 7.77% | |
Share Based Compensation of Revenue |
0.36% | 0.38% | 0.33% | 0.28% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.94 | 0.62 | 0.68 | 1.21 | |
Depreciation/Fixed assets |
24.55 | 28.96 | 33.81 | 39.85 | |
Capex/Depreciation |
(0.02) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
442.15 | 446.34 | 447.76 | 447.01 | |
Operating CF per Share |
(37.56) | (27.91) | (25.92) | (38.82) | |
Capex per Share |
(0.45) | (0.03) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(9.07%) | (10.14%) | (8.57%) | (7.19%) |
Columns are period end dates